Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29151 - 29175 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Dasatinib	Approved Investigational	MCM7	4176	downregulated	Dasatinib results in decreased expression of MCM7 mRNA	7q22.1	A21899
Dasatinib	Approved Investigational	MCM8	84515	downregulated	Dasatinib results in decreased expression of MCM8 mRNA	20p12.3	A21899
Dasatinib	Approved Investigational	MDGA1	266727	upregulated	Dasatinib results in increased expression of MDGA1 mRNA	6p21.2	A21899
Dasatinib	Approved Investigational	MELK	9833	downregulated	Dasatinib results in decreased expression of MELK mRNA	9p13.2	A21899
Dasatinib	Approved Investigational	MFAP4	4239	upregulated	Dasatinib results in increased expression of MFAP4 mRNA	17p11.2	A21899
Dasatinib	Approved Investigational	MFGE8	4240	upregulated	Dasatinib results in increased expression of MFGE8 mRNA	15q26.1	A21899
Dasatinib	Approved Investigational	MGME1	92667	downregulated	Dasatinib results in decreased expression of MGME1 mRNA	20p11.23	A21899
Dasatinib	Approved Investigational	MGP	4256	upregulated	Dasatinib results in increased expression of MGP mRNA	12p12.3	A21899
Dasatinib	Approved Investigational	MIS18A	54069	downregulated	Dasatinib results in decreased expression of MIS18A mRNA	21q22.11	A21899
Dasatinib	Approved Investigational	MIS18BP1	55320	downregulated	Dasatinib results in decreased expression of MIS18BP1 mRNA	14q21.2	A21899
Dasatinib	Approved Investigational	MKI67	4288	downregulated	Dasatinib results in decreased expression of MKI67 mRNA	10q26.2	A21899
Dasatinib	Approved Investigational	MMP1	4312	downregulated	Dasatinib results in decreased expression of MMP1 mRNA	11q22.2	A21899
Dasatinib	Approved Investigational	MMS22L	253714	downregulated	Dasatinib results in decreased expression of MMS22L mRNA	6q16.1	A21899
Dasatinib	Approved Investigational	MND1	84057	downregulated	Dasatinib results in decreased expression of MND1 mRNA	4q31.3	A21899
Dasatinib	Approved Investigational	MRVI1	10335	upregulated	Dasatinib results in increased expression of MRVI1 mRNA	11p15.4	A21899
Dasatinib	Approved Investigational	MSH2	4436	downregulated	Dasatinib results in decreased expression of MSH2 mRNA	2p21-p16.3	A21899
Dasatinib	Approved Investigational	MTBP	27085	downregulated	Dasatinib results in decreased expression of MTBP mRNA	8q24.12	A21899
Dasatinib	Approved Investigational	MTFR2	113115	downregulated	Dasatinib results in decreased expression of MTFR2 mRNA	6q23.3	A21899
Dasatinib	Approved Investigational	MYBL1	4603	downregulated	Dasatinib results in decreased expression of MYBL1 mRNA	8q13.1	A21899
Dasatinib	Approved Investigational	MYBL2	4605	downregulated	Dasatinib results in decreased expression of MYBL2 mRNA	20q13.12	A21899
Dasatinib	Approved Investigational	MYH10	4628	upregulated	Dasatinib results in increased expression of MYH10 mRNA	17p13.1	A21899
Dasatinib	Approved Investigational	MYH11	4629	upregulated	Dasatinib results in increased expression of MYH11 mRNA	16p13.11	A21899
Dasatinib	Approved Investigational	MYLK	4638	upregulated	Dasatinib results in increased expression of MYLK mRNA	3q21.1	A21899
Dasatinib	Approved Investigational	MYPN	84665	downregulated	Dasatinib results in decreased expression of MYPN mRNA	10q21.3	A21899
Dasatinib	Approved Investigational	NCAPD2	9918	downregulated	Dasatinib results in decreased expression of NCAPD2 mRNA	12p13.31	A21899

Displaying entries 29151 - 29175 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability